In January 2020, the World Health Organization raises an alarm over the spread of an infectious disease caused by the newly discovered Severe Acute Respiratory Syndrome (SARS-CoV-2) and names it COVID-19. Although there is currently no specific treatment for COVID-19, after nearly a year of fighting coronavirus, several unregistered drugs remain approved for clinical trials worldwide, including theranostic nanoparticles used in nanomedicine.